KEENE, N.H.--(BUSINESS WIRE)--

G2 Intelligence a 30+ year leader in research, reporting, and analysis on the business of the diagnostic lab industry today announced the final agenda for MDx NEXT, with dynamic sessions, case studies, and interactive panel discussions surrounding the theme: Gaining Ground in Molecular Testing and Genomic Medicine. G2s annual event will be held in a new city at a new venue this year: the Westin Las Vegas Hotel Casino & Spa, June 12-14, 2013.

Everyone with a stake in molecular diagnostics can look forward to expert insight and advice on how clinical laboratories of all sizes are successfully using molecular testing, despite the challenging regulatory and ever-changing business environments, said Stephanie Murg, G2s Managing Director and conference program chair. In fact, with genomic medicine firmly established and growing rapidly, the time is ideal for labs to find out how they can actively harness the evolving markets clinical utility, latest technology, and novel business models to grow. This years conference is dedicated to that purpose.

Industry professionals who want to know where the market is headed wont want to miss this years conference, continues Kimberly Scott, G2s Managing Editor and program co-chair. The agenda is oriented toward a broad range of labs, and will also tackle such hot-button topics as reimbursement, building a more cost-effective test menu, and the prospects for next-generation sequencing.

Confirmed sessions to include:

Attendees are encouraged to make the most of their experience with one or both pre-conference workshops on Wednesday, June 12:

MDx NEXT keynote speakers are:

Distinguished faculty in attendance to include:

To find out more, or to register for G2s MDx NEXT conference, go to http://www.MDxConference.com, call 1-800-531-1026, or email customerservice@G2Intelligence.com.

Group discounts are available for 3 or more people from the same organization. For group registrations, please call Jeff Watkins at 973-718-4709 to facilitate your registration, or email jwatkins@G2Intelligence.com.

More here:

Annual Conference to Address Key Operational and Business Concerns of Genomic Medicine